Merck & Co Osake

Merck & Co Termiini P/E

Forward P/E -suhde yhtiöstä Merck & Co (MRK) 6.8.2026 päivämäärällä on 16,51. Edellisenä vuonna Forward P/E -suhde oli 17,60 — muutos −6,23 % (matalampi).

Termiini P/E

16,51

YoY

−6,23%

Viimeksi päivitetty:

Forward P/E -suhde yhtiöstä Merck & Co on 2026 16,51 . Forward P/E -suhde yhtiöstä Merck & Co oli 2025 17,60 . Se laskee −6,23% matalampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Merck & Co Osakeanalyysi

Mitä Merck & Co tekee? The company Merck & Co Inc has a long history. It was founded in 1891 by the German pharmacist Friedrich Jacob Merck and is now based in Kenilworth, New Jersey, USA. The company has evolved over time into a globally operating company in the pharmaceutical and chemical industry. Merck & Co Inc's business model is based on the development, production, and marketing of medicines and products for the healthcare industry. The company collaborates with other partners such as universities, other companies, and governments to achieve the best possible scientific progress. Research and development play a very important role in this. Merck is divided into three main areas: The Human Health division, which specializes in the development of prescription drugs and products to improve human health. The second division is Animal Health, which focuses on animal medicines and care products. The third division, Life Science (formerly MilliporeSigma), is dedicated to the development of products and services for biopharmaceutical research and production to facilitate the discovery and manufacturing of medicines. Merck & Co Inc. offers a wide range of products, ranging from prescription medicines to specialty chemicals. Some of the most well-known drugs include Januvia for the treatment of type 2 diabetes and Keytruda, an immuno-oncology drug used in the treatment of various types of cancer. Other well-known drugs from Merck & Co Inc. include Gardasil for the prevention of HPV infections, Propecia for the treatment of male pattern hair loss, and Zetia for the treatment of high cholesterol. The company is extremely innovative and has made significant advances in pharmaceutical research in recent decades. Merck & Co Inc. has won numerous awards over the years, including the "2018 Australian Financial Review Boss Most Innovative Companies Award" and the "2018 Global Energy Award for Technology Innovation". Merck & Co Inc. operates worldwide and has subsidiaries and partnerships in many countries. The company has about 69,000 employees and distributes its products in over 140 countries. Merck & Co Inc.'s products are typically prescription-only and prescribed by doctors and professionals. Overall, Merck & Co Inc. is a company with an impressive history that is now one of the leading companies in the pharmaceutical and chemical industry. Thanks to its innovation and its consistent focus on the needs of patients and healthcare professionals, it is able to successfully meet challenges in the healthcare industry and set new standards. Merck & Co on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Merck & Co osakkeesta

Yhtiön Merck & Co Forward P/E -suhde on 16,51 vuonna 2026.

Forward P/E -suhde yhtiöstä Merck & Co muuttui arvosta 17,60 arvoon 16,51, mikä edustaa −6,23 % muutosta. Arvo on matalampi kuin edellisenä vuonna.

Eurpoolissa voit löytää Forward P/E -suhde Merck & Co:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

Forward P/E käyttää arvioituja tulevia voittoja osakkeen arvostukseen. Pienempi forward P/E peräkkäiseen P/E:hen verrattuna viittaa analyytikkojen odottavan tuloksen kasvua.

Arvioidakseen Forward P/E -suhde:n, on olennaista verrata sitä saman alan ja sektorin kilpailijoihin. Eulerpoolissa voit löytää suoria alan vertailuja Forward P/E -suhde:lle.

"Hyvä" vaihtelee alan ja yrityksen kehitysvaiheen mukaan. Eulerpoolissa voit verrata Forward P/E -suhde:n Merck & Co alan vertaisiin ja alan keskiarvoon arvioidaksesi houkuttelevuuden.

Access this data via the Eulerpool API

Arvostus — Merck & Co

Kaikki tunnusluvut — Merck & Co